The Necroptosis Effector MLKL drives Small Extracellular Vesicle Release and Tumour Growth in Glioblastoma - Archive ouverte HAL Access content directly
Preprints, Working Papers, ... Year :

The Necroptosis Effector MLKL drives Small Extracellular Vesicle Release and Tumour Growth in Glioblastoma

(1, 2) , (1) , (1) , (1) , (1) , (1) , (1) , (3) , (3) , (1) , (1) , (4, 1, 2)
1
2
3
4

Abstract

Abstract Extracellular vesicles (EVs) are lipid-based nano-sized particles that convey biological material from donor to recipient cells. They play key roles in tumour progression, notably in glioblastoma in which the subpopulation of Glioblastoma Stem-like Cells (GSCs) might represent a meaningful source of tumour-derived EVs. However, the mechanisms involved in the production and release of EVs by GSCs are still poorly understood. Here, we report the identification of MLKL, a crucial effector of cell death by necroptosis, as a regulator of the constitutive secretion of small EVs from GSCs. The targeting of MLKL by genetic, protein depletion or chemical approaches alters endosomal trafficking and EV release and reduces GSC expansion in vitro . This function ascribed to MLKL appears independent of its role during necroptosis. In vivo , pharmacological inhibition of MLKL triggers a reduction of both the tumour burden in xenografted mice and of the level of plasmatic EVs. This work reinforces the idea of a non-deadly role for MLKL in endosomal trafficking and suggests that interfering with EV biogenesis is a promising therapeutic option to sensitize glioblastoma cells to death.
Embargoed file
Embargoed file
Ne sera jamais visible

Dates and versions

inserm-03379904 , version 1 (15-10-2021)

Identifiers

Cite

Gwennan André-Grégoire, Tiphaine Douanne, An Thys, Clément Maghe, Kathryn Jacobs, et al.. The Necroptosis Effector MLKL drives Small Extracellular Vesicle Release and Tumour Growth in Glioblastoma. 2021. ⟨inserm-03379904⟩
29 View
10 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More